Whereas the overexpression of ERG alone does not constitute a determinant for disease progression or overall survival [14,15], it could indicate the initiating trigger for the gene fusion upon other cancer cell regulatory pathways, such as a loss of PTEN, and thus reflect disease aggressiveness [16,17,18,19,20,21]. Here, PTEN is linked to cancer.